AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUDGES SCIENTIFIC PLC

Transaction in Own Shares Dec 22, 2025

7734_rns_2025-12-22_df54f812-e773-4bb3-ba53-885f39002edf.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3114M

Judges Scientific PLC

22 December 2025

Press Release

Judges Scientific plc

("Judges Scientific", "Judges", the "Company" or the "Group") 

Blocklisting Return

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, gives below the information required by Schedule 6 of the AIM Rules for Companies in connection with the Judges Scientific plc Share Option Schemes.

Name of applicant: Judges Scientific plc
Name of scheme: Judges' Approved and Unapproved Share Option Schemes
Period of return: From: 21 June 2025 To: 21 December 2025
Balance under scheme from previous return: 67,264 Ordinary Shares
The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:
Number of securities issued/allotted under scheme during period: 3,100 Ordinary Shares
Balance under scheme not yet issued/allotted at end of period 64,164 Ordinary Shares
Number and class of securities originally listed and the date of admission 100,000 Ordinary Shares on 13 May 2015, a further 100,000 Ordinary Shares on 24 January 2018, a further 100,000 Ordinary Shares on 7 February 2020 and a further 100,000 on 5 June 2023
Total number of securities in issue at the end of the period 6,651,052 Ordinary Shares
Name of contact: Brad Ormsby
Telephone number of contact: Tel:  020 3829 6970

- Ends - 

For further information please contact: 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970
Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090
Panmure Liberum (Joint Broker)

Edward Mansfield

William King

Tel : +44 (0) 20 3100 2222
Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 20 7597 4000
Alma (Financial Public Relations)

Sam Modlin

Rebecca Sanders-Hewett

Joe Pederzolli

Sarah Peters

Tel: +44 (0) 20 3405 0205

[email protected]

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector.  The Group consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLREAEANFSXSFFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.